Pulmonary arterial hypertension in autoimmune diseases: An analysis of 19 cases from a medical center in northern Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 39, Issue 2, 2006, Pages 162-168

  Chen, Chun Hsiung ^a,b   Chen, Horng An ^a   Wang, Hong Pin ^a   Liao, Hsien Tzung ^a,b   Chou, Chung Tei ^a   Huang, De Feng ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Autoimmune diseases; Pulmonary diffusion capacity; Pulmonary hypertension; Taiwan; Uric acid

Indexed keywords

CARBON MONOXIDE; URIC ACID;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GENERAL HOSPITAL; HEART RIGHT VENTRICLE PRESSURE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; LUNG DIFFUSION CAPACITY; MALE; MIXED CONNECTIVE TISSUE DISEASE; MORTALITY; PULMONARY HYPERTENSION; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; SYSTOLIC BLOOD PRESSURE; TAIWAN; URIC ACID BLOOD LEVEL;

ADULT; AGED; ANTIBODIES, ANTINUCLEAR; AUTOIMMUNE DISEASES; FEMALE; HOSPITALS; HUMANS; HYPERGAMMAGLOBULINEMIA; HYPERTENSION, PULMONARY; MALE; MIDDLE AGED; PNEUMONIA; RAYNAUD DISEASE; TAIWAN; URIC ACID; VENTRICULAR PRESSURE;

EID: 33745454531     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Simonneau G, Galie N, Rubin LJ, Langleben D, Seeger W, Domenighetti G, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004;16(12 Suppl S):5S-12S.
2. Ungerer RG, Tashkin DP, Furst D, Clements PJ, Gong H Jr, Bein M, et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983;75:65-74.
3. Stupi AM, Steen VD, Owens GR, Barnes EL, Rodnan GP, Medsger TA Jr. Pulmonary hypertension in the CREST syndrome variant of systemic sclerosis. Arthritis Rheum 1986; 29:515-24.
4. Quismorio FP Jr, Sharma O, Koss M, Boylen T, Edmiston AW, Thornton PJ, et al. Immunopathologic and clinical studies in pulmonary hypertension associated with systemic erythematosus. Semin Arthritis Rheum 1984;13:349-59.
5. Sullivan WD, Hurst DJ, Harmon CE, Esther JH, Agia GA, Maltby JD, et al. A prospective evaluation emphasizing pulmonary involvement in patients with mixed connective tissue disease. Medicine (Baltimore) 1984;63:92-107.
6. Nakagawa N, Osanai S, Ide H, Nishigaki Y, Takahashi S, Nakano H, et al. Severe pulmonary hypertension associated with primary Sjögren's syndrome. Intern Med 2003;42:1248-52.
7. Koh ET, Lee P, Gladman DD, Abu-Shakra M. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 1996;35:989-93.
8. Rolla G, Colagrande P, Scappaticci E, Chiavassa G, Dutto L, Cannizzo S, et al. Exhaled nitric oxide in systemic sclerosis: relationships with lung involvement and pulmonary hypertension. J Rheumatol 2000;27:1693-8.
9. Li EK, Tam LS. Pulmonary hypertension in systemic lupus erythematosus: clinical association and survival in 18 patients. J Rheumatol 1999;26:1923-9.
10. Rich S, Dantzker DR, Ayres SM, Bergofsky EH, Brundage BH, Detre KM, et al. Primary pulmonary hypertension. A national prospective study. Ann Intern Med 1987;107:216-23.
11. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
12. Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, et al; European Study Group on Classification Criteria for Sjögren's Syndrome. Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis 2002;61:554-8.
13. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
14. Alarcon-Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC, eds. Mixed connective tissue diseases and anti-nuclear antibodies. Amsterdam: Elsevier; 1987:33-40.
15. Yamaguchi M, Ohta A, Tsunematsu T, Kasukawa R, Mizushima Y, Kashiwagi H, et al. Preliminary criteria for classification of adult Still's disease. J Rheumatol 1992;19: 424-30.
16. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol 2004;43 (12 Suppl S):13S-24S.
17. Steen V, Medsger TA Jr. Predictors of isolated pulmonary hypertension in patients with systemic sclerosis and limited cutaneous involvement. Arthritis Rheum 2003;48:516-22.
18. Voelkel MA, Wynne KM, Badesch DB, Groves BM, Voelkel NF. Hyperuricemia in severe pulmonary hypertension. Chest 2000;117:19-24.
19. Nagaya N, Uematsu M, Satoh T, Kyotani S, Sakamaki F, Nakanishi N, et al. Serum uric acid levels correlate with the severity and the mortality of primary pulmonary hypertension. Am J Respir Crit Care Med 1999;160:487-92.
20. Bendayan D, Shitrit D, Ygla M, Huerta M, Fink G, Kramer MR. Hyperuricemia as a prognostic factor in pulmonary arterial hypertension. Respir Med 2003;97:130-3.
21. Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997;18: 858-65.
22. Anker SD, Leyva F, Poole-Wilson PA, Kox WJ, Stevenson JC, Coats AJ. Relation between serum uric acid and lower limb blood flow in patients with chronic heart failure. Heart 1997; 78:39-43.
23. Hasday JD, Grum CM. Nocturnal increase of urinary uric acid: creatinine ratio. A biochemical correlate of sleep-associated hypoxemia. Am Rev Respir Dis 1987;135:534-8.
24. Ross EA, Perloff JK, Danovitch GM, Child JS, Canobbio MM. Renal function and urate metabolism in late survivors with cyanotic congenital heart disease. Circulation 1986;73: 396-400.
25. Wigley FM. Raynaud's phenomenon and other features of scleroderma, including pulmonary hypertension. Curr Opin Rheumatol 1996;8:561-8.
26. Kitridou RC, Akmal M, Turkel SB, Ehresmann GR, Quismorio FP Jr, Massry SG. Renal involvement in mixed connective tissue disease: a longitudinal clinicopathologic study. Semin Arthritis Rheum 1986;16:135-45.
27. Bennett RM, Spargo BH. Immune complex nephropathy in mixed connective tissue disease. Am J Med 1977;63:534-41.
28. Sacks DG, Okano Y, Steen VD, Curtiss E, Shapiro LS, Medsger TA Jr. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody. J Rheumatol 1996;23:639-42.
29. Amigues JM, Cantagrel A, Abbal M, Mazieres B. Comparative study of 4 diagnosis criteria sets for mixed connective tissue disease in patients with anti-RNP antibodies. Autoimmunity Group of the Hospitals of Toulouse. J Rheumatol 1996;23:2 055-62.
30. Hainaut P, Lavenne E, Magy JM, Lebacq EG. Circulating lupus type anticoagulant and pulmonary hypertension associated with mixed connective tissue disease. Clin Rheumatol 1986;5: 96-101.
31. Sato T, Matsubara O, Tanaka Y, Kasuga T. Association of Sjögren's syndrome with pulmonary hypertension: report of two cases and review of the literature. Hum Pathol 1993; 24:199-205.